Venture
Showing 121–150 of 156 results
-
VenturePinot Bio
PinoBio is a company that focuses on the development of Antibody-Drug Conjugates (ADC) for cancer treatment.
-
VenturePnP Biopharm
PnP Biopharm Co., Ltd. established in 2011, is leading R&D institute and manufacturer for growth factors and peptides
-
VenturePosvax
Posvax is a biopharmaceutical company that develops and produces vaccines for various diseases, such as HPV, RSV, and COVID-19. They have a strong R&D center and a global patent portfolio. They are committed to developing high-quality vaccines to protect people from various diseases.
-
VenturePrimoris Therapeutics
BoostStem™ is umbilical cord blood stem cell isolation/cultivation technology that induces high expression of the ‘GDF-3’ gene, which enhances stem cell characteristics.
-
-
VenturePsomagen
Psomagen is a multiomics contract laboratory service and data analysis provider with both CLIA-certified and CAP-accredited facilities. They offer a range of services including genomics, epigenomics, bioinformatics, proteomics, metagenomics, and transcriptomics.
-
VentureQuratis
Quratis is a company that focuses on the development of vaccines. They are developing a tuberculosis vaccine (QTP101) and a COVID-19 vaccine (QTP104). They also have a platform for Peptide Nucleic Acid (PNA), a synthetic analogue of DNA in which the deoxyribose phosphate backbone is replaced by a polyamide chain.
-
-
VentureRenhaim Therapeutics Inc.
-
VentureRUDACURE
RudaCure is a biotechnology company founded in 2018 that is developing treatments for incurable diseases with high unmet needs.
-
VentureRznomics
Rznomics is a biotech company that develops gene therapies for cancer and incurable diseases based on RNA Platform technology. They aim to meet various unmet medical needs through their innovative gene therapies. Their RNA platform technology allows them to develop a wide range of therapeutics for various diseases.
-
VentureS.Biomedics
S.Biomedics is a company specializing in the research and development of cell therapies for regenerative biomedicine.
-
VentureS&E Bio
-
VentureSanigen
Sanigen provides a food safety total solution for the manufacture, distribution, and sale of safe food. They strive to contribute to the development of the Korean food industry.
-
-
VentureShaperon
Shaperon is a clinical stage biotech company developing Novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and Nanobody therapeutics
-
VenturesiRNAgen Therapeutics
siRNAgen’s pioneering SAMiRNA platform harnesses modular chemistry and self-assembly to expand delivery of RNAi beyond the liver and ultimately make treatments easier on patients. The platform’s unique chemistry leverages supramolecular interactions to form a micellar structure with the oligonucleotide at its core. This design allows the incorporation of specific targeting moieties, broadening the delivery possibilities to target tissues.
-
VentureSMT Bio
SMT bio Co., Ltd. was founded in 2015 for developing NK cell immuno-therapeutics and now the company is developing the drug to treat rare and refractory cancers such as biliary tract cancer.
-
VentureSolGent Co., Ltd.
-
VentureSTC Bio
A research-centered company such as stem cell research and development, aging related p62 gene action mechanism and anti-aging product development, new drug development, energy water business and agricultural science research and development, is going to contribute to the mankind and lead the 4th industrial revolution.
-
VentureStemLab
-
VentureSTR Biotech Co., Ltd.
Phagocytosis enhancer for the support treatment of cancer, autoimmune, and other serious diseases
-
VentureSumagen
Sumagen Co., Ltd. is a biotechnology company and a member of Curo Group. Sumagen holds Exclusive License for Dr. Kang, Chil-Yong’s HIV/AIDS vaccine development and its commercialization. Sumagen is also holder of a Preferred Bidding Rights for the development and subsequent production and marketing for HCV (Hepatitis C Virus) vaccine and the next generation antibiotics of Dr. Heinrich
-
VentureTHERABEST
RNK™ (mRNA based NK cell) is an autologous CAR-NK cell therapy platform that introduces mRNA technology to NK cell mass expansion.
EiNK™ (Enhanced iPSC-derived NK cell) is an allogeneic CAR-NK cell therapy platform in which non-viral gene editing technology is used in iPSCs prior to NK cell differentiation. -
VentureTiCARos
TiCARos proposes a new treatment option using cutting-edge technology in immunology and antibody-engineering. TiCARos develops best-in class, first-in class therapies based on Converter CAR platform for better T cell activity and on CLIP CAR platform for more stable immune synapse of CAR-T cells.
-
VentureTSD Life Science
-
-
VentureVaxcell Bio Therapeutics
Vaxcell-bio aims for fundamental chemotherapy that encompasses all components of the immune system
-
VentureVigenCell
VIGENCELL is a company that focuses on the development of drugs using nano platform technology.
-
